2017 - Nowember
HVMN exclusively launch HVMN Ketone for athletes in the USA.
Strategising and building momentum for both production scale-up and commercialisation.
Publication in Frontiers in Physiology of On the metabolism of exogenous ketones in humans. Stubbs B et al.
Publication in Obesity of A ketone ester drink lowers human ghrelin and appetite. Stubbs B et al.
Discussions with Silicon Valley start-up company, HVMN Inc., about commercialising ΔG® as a drink for elite athletes in the USA.
Publication in Cell Metabolism of Nutritional ketosis alters fuel preference and thereby endurance performance in athletes. Cox P et al.
2015 - 2016
Investigated the effect of ΔG® on production of hunger hormone, ghrelin.
Established that D- and L-beta-hydroxybutyrate are metabolised at different rates.
2013 - 2015
Worked on Centre for Defence Enterprise grant to determine whether ΔG® prevents glycogen loss during extreme exercise in athletes.
With support from the Royal Commission for the Exhibition of 1851, worked on the metabolism of ΔG® as compared to ketone salts already available on the market.
Identified a potential manufacturer for the scale-up of production.
Working on Centre for Defence Enterprise grant to determine whether ΔG® prevents cognitive dysfunction during extreme exercise (mimicking battlefield conditions) in athletes.
Human physical performance studies in elite athletes yielded 1 world record, 6 personal bests and 10 season`s bests.
Confirmed ΔG® is not on WADA`s banned list of substances for athletes.
Licenced 13 patents from BTG International Ltd. Licenced 5 patents from Oxford University Innovation.